Summary

Report Overview
Global Medicinal Foods Market reached US$ 21.3 billion in 2023 and is expected to reach US$ 34.1 billion by 2031, growing with a CAGR of 6.06% during the forecast period 2024-2031. 
The global medicinal foods market is experiencing robust growth driven by increasing health awareness among the global population. The rising prevalence of chronic diseases and an aging population seeking dietary solutions for managing health conditions and enhancing overall well-being. Medicinal foods provide a variety of benefits that extend beyond standard nutrition, aiding in health maintenance and the management of diseases and expanding the market reach.
Advances in food science and technology, along with supportive regulatory frameworks, are expanding the range of products available in different types of medicinal foods. Significant opportunities for market growth lie in emerging markets, where rising incomes and changing lifestyles drive demand, as well as through product innovation, such as personalized nutrition and plant-based ingredients. 
North America's dominance in the global medicinal foods market is evident from the high consumer engagement in health and wellness, and the demand for nutritional dependency with the involvement of dietary supplements. According to a study by the Council for Responsible Nutrition, a significant portion of adults in US, 2,342 out of 3,133 surveyed, reported using dietary supplements regularly or seasonally.
Market Dynamics
Rising Prevalence of Chronic Diseases
The rising prevalence of chronic diseases, such as obesity, diabetes and heart disease, is significantly driving the market for products that improve the overall well-being of a person. According to the World Health Organization's statistics, about 1 billion people worldwide are affected by obesity, with 650 million being adults and over 340 million adolescents. 
Additionally, the IDF Diabetes Atlas reports that 537 million adults globally are living with diabetes, which is expected to rise to 643 million by 2030. Further, WHO estimates that cardiovascular diseases are the top cause of death worldwide, accounting for approximately 17.9 million fatalities annually. As people become more health-conscious and seek ways to better health, the demand for food products that add medicinal is increasing rapidly driving the market growth.
Innovative Product Launches
New and innovative product launches are a significant driver for growth in the global medicinal foods market focussing on foods designed to provide specific health benefits beyond basic nutrition. For instance, in March 2022, Lanfam LLC introduced Proleeva, a medical food aimed at alleviating chronic pain and inflammatory disorders. 
Proleeva works by addressing amino acid deficiencies, reducing free radicals, boosting antioxidant levels, enhancing neurotransmitter activity and managing oxidative stress. Similarly, in December 2021, SFI Health launched two new medical foods EQUAZEN PRO, which balances omega-6/omega-3 levels in ADHD and supports brain health and Ther-Biotic PRO IBS Relief in US. The latter addresses IBS by strengthening the gut barrier and balancing gut microbiota to reduce symptoms.
High Costs of Medicinal Foods
High costs associated with the development, production and marketing of medicinal foods significantly restrain the growth of the global market. These expenses encompass extensive research and development, rigorous clinical trials and navigating complex regulatory approval processes. As a result, companies face substantial financial barriers that can limit their ability to introduce new products and scale up production efficiently. 
The financial strain hampers innovation and market entry and also creates a competitive disadvantage. Preferences and acceptance of medicinal foods can vary widely across different cultures and regions. With the higher costs of these products, consumers look out for replacements to complement the medicinal benefits with a cheaper range. Medicinal foods often compete with pharmaceuticals and traditional treatments.
Market Segment Analysis
The global medicinal foods market is segmented based on product, form, health benefits, route of administration, distribution channel and region.
Increasing Digestive Health Issues 
The global medicinal foods market is segmented based on health benefits into digestive health, cardiovascular health, immune support and others. The digestive health segment accounted for the largest share of the global market. There is increasing awareness about the importance of gut health and its connection to overall well-being. This awareness has led to greater consumer interest in medicinal foods. 
The high prevalence of gastrointestinal issues highlights the dominance of digestive health in the global medicinal foods market. According to a comprehensive multinational study by the National Institutes of Health, over 40% of the global population suffers from gastrointestinal problems, with diarrhea affecting 4.7%, constipation 11.7% and irritable bowel syndrome (IBS) 4.1% of people. 
The widespread occurrence creates substantial demand for products designed to support digestive health, such as probiotics, prebiotics and fiber-enriched foods. The significant number of individuals experiencing these conditions drives the market for medicinal foods aimed at alleviating symptoms and promoting overall digestive well-being, underscoring the importance of this segment in addressing a major global health concern.
Market Geographical Share
Rising Prevalence of Health Concerns in North America
North America dominates the global medicinal foods market. Regional consumers are increasingly seeking out medicinal foods for their potential health benefits, such as managing diabetes, improving cardiovascular health and enhancing overall wellness. There is a high prevalence of obesity and diabetes in North America, affecting over 41.9% of adults, 19.7% of children with obesity, and approximately 37.3 million Americans with diabetes.
The widespread health challenge creates a high demand for medicinal foods tailored to manage these conditions, leading to extensive innovation and the development of specialized products. The presence of a highly developed healthcare system and rapid investments in R&D for pharmaceuticals and nutritional sciences fuels the development of new medicinal foods and dietary supplements in the region fueling the market growth.
Market Competitive Landscape
The major global players in the market include B Braun SE, Abbott Nutrition, Danone S.A., Mead Johnson & Company, LLC., Meiji Holding & Co, Ltd., Ajinomoto Cambrooke Inc., Nestle Health Sciences, Perrigo Company plc., Dutch Medical Food BV. and Hearthside Food Solutions, LLC.
By Product
Herbal Supplements
Functional Foods
Nutraceuticals
Other
By Form
Powder
Tablet
Others
By Health Benefits
Digestive Health
Cardiovascular Health
Immune Support
Other
By Route of Administration
Oral
Enteral
Others
By Distribution Channel
Pharmacies
Supermarkets/Hypermarkets
Specialty Stores
Online Retail
Others
By Region
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
Middle East and Africa
Key Developments
In March 2023, Nutrazee, an Indian company, unveiled Nutrazee Probiotic Gummies, which are designed to enhance digestive and immune health for both children and adults. 
In November 2022, Geno entered the functional foods and beverages market with its new ingredient, Avela natural (R)-1,3-Butanediol. Debuting at SupplySide West 2022 in Las Vegas, this sugar-free ingredient boosts beta-hydroxybutyrate ketone levels, the body's primary energy source during ketosis.
In March 2022, Lanfam LLC introduced Proleeva, a medical food aimed at alleviating chronic pain and inflammatory disorders. Proleeva works by addressing amino acid deficiencies, reducing free radicals, boosting antioxidant levels, enhancing neurotransmitter activity and managing oxidative stress.
Why Purchase the Report?
To visualize the global medicinal foods market segmentation based on product, form, health benefits, route of administration, distribution channel and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development. 
Excel data sheet with numerous data points of the medicinal foods market with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.
The global medicinal foods market report would provide approximately 78 tables, 76 figures and 231 pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by Form
3.3. Snippet by Health Benefits
3.4. Snippet by Route of Administration
3.5. Snippet by Distribution Channel
3.6. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Prevalence of Chronic Diseases
4.1.1.2. Innovative Product Launches
4.1.2. Restraints
4.1.2.1. High Costs of Medicinal Foods
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. By Product
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
6.1.2. Market Attractiveness Index, By Product
6.2. Herbal Supplements
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Functional Foods
6.4. Nutraceuticals
6.5. Other
7. By Form
7.1. Introduction
7.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
7.3. Market Attractiveness Index, By Form
7.4. Powder
7.4.1. Introduction
7.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.5. Tablet
7.6. Others
8. By Health Benefits
8.1. Introduction
8.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
8.3. Market Attractiveness Index, By Health Benefits
8.4. Digestive Health
8.4.1. Introduction
8.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.5. Cardiovascular Health
8.6. Immune Support
8.7. Other
9. By Route of Administration
9.1. Introduction
9.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
9.3. Market Attractiveness Index, By Route of Administration
9.4. Oral
9.4.1. Introduction
9.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.5. Enteral
9.6. Others
10. By Distribution Channel
10.1. Introduction
10.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.3. Market Attractiveness Index, By Distribution Channel
10.4. Pharmacies
10.4.1. Introduction
10.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.5. Supermarkets/Hypermarkets
10.6. Specialty Stores
10.7. Online Retail
10.8. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.8.1. US
11.2.8.2. Canada
11.2.8.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.8.1. Germany
11.3.8.2. UK
11.3.8.3. France
11.3.8.4. Italy
11.3.8.5. Spain
11.3.8.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.8.1. Brazil
11.4.8.2. Argentina
11.4.8.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.8.1. China
11.5.8.2. India
11.5.8.3. Japan
11.5.8.4. Australia
11.5.8.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. B Braun SE
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Abbott Nutrition
13.3. Danone S.A.
13.4. Mead Johnson & Company, LLC.
13.5. Meiji Holding & Co, Ltd.
13.6. Ajinomoto Cambrooke Inc.
13.7. Nestle Health Sciences
13.8. Perrigo Company plc
13.9. Dutch Medical Food BV.
13.10. Hearthside Food Solutions, LLC (*LIST NOT EXHAUSTIVE)
14. Appendix
14.1. About Us and Services
14.2. Contact Us